Protodesnitazene

  1. Home
  2. Wiki
Protodesnitazene
Identifiers
  • N,N-diethyl-2-[2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine
CAS Number
PubChem CID
ChemSpider
UNII
Chemical and physical data
FormulaC23H31N3O
Molar mass365.521 g·mol−1
3D model (JSmol)
  • CCCOC1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCN(CC)CC
  • InChI=1S/C23H31N3O/c1-4-17-27-20-13-11-19(12-14-20)18-23-24-21-9-7-8-10-22(21)26(23)16-15-25(5-2)6-3/h7-14H,4-6,15-18H2,1-3H3
  • Key:CEHFMRGBRNNSCM-UHFFFAOYSA-N

Protodesnitazene is a benzimidazole derivative which has been sold as a designer drug, and has potent opioid effects. It has been identified in Canada, Australia and the United Kingdom, first appearing in early 2025.[1][2][3][4][5]

See also

[edit]

References

[edit]
  1. ^ "High Risk Substance Detected In Fentanyl Trafficking Investigation". Sarnia Police Service. Sarnia Police Service. 13 March 2025. Retrieved 17 August 2025.
  2. ^ "Fredericton Police Warn of New, Potentially Fatal Street Drug". City of Fredericton. Fredericton Police. 9 April 2025. Retrieved 17 August 2025.
  3. ^ "New nitazene (strong opioid) Protodesnitazene detected" (PDF). Queensland Health. Queensland Government. March 2025. Retrieved 17 August 2025.
  4. ^ Gwynn L (4 April 2025). "Nitazines found in black market vapes as criminals make new variations to evade detection". ABC News. Australian Broadcasting Corporation. Retrieved 17 August 2025.
  5. ^ "Rapid Action Drug Alerts and Response (RADAR) Alert: Nitazenes". Public Health Scotland. NHS Scotland. 12 August 2025. Retrieved 17 August 2025.



Stub icon

This analgesic-related article is a stub. You can help Wikipedia by expanding it.